Soergel David
SEC insider (Form 3/4/5 filer). CIK 0001591475. Chief Medical Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in WEST CONSHOHOCKEN, PA.
Companies Soergel David has filed insider reports for
- MADRIGAL PHARMACEUTICALS, INC. (MDGL): Officer, Chief Medical Officer
Soergel David
CIK: 0001591475
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MDGL
MADRIGAL PHARMACEUTICALS, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 1, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect1K shares at avg. $495.74$517K - May 18, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect844 shares at avg. $515.90$435K - Mar 4, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
AwardDirect4.4K shares- - May 15, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
AwardDirect7.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,042 | $495.74 | $516,561 | Direct |
| May 18, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 844 | $515.90 | $435,420 | Direct |
| Mar 4, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Award | 4,374 | - | $0 | Direct |
| May 15, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Award | 7,545 | - | - | Direct |
1-4 of 4 transactions